Neuren Pharmaceuticals Limited

ASX:NEU Stock Report

Market Cap: AU$1.7b

Neuren Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:NEU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 24BuyAU$100,766Joe BasileIndividual6,406AU$15.73
17 Jul 24BuyAU$132,031,307Milford Asset Management, LTDCompany8,499,600AU$15.53
17 Jul 24SellAU$131,556,262Milford Asset Management, LTDCompany9,003,256AU$14.61
11 Jun 24BuyAU$97,450Joe BasileIndividual5,000AU$19.49

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NEU?
Owner TypeNumber of SharesOwnership Percentage
Public Companies404,0720.316%
Individual Insiders4,235,3313.31%
Private Companies12,359,0129.67%
Institutions22,882,68617.9%
General Public87,934,57568.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 31.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.96%
The Vanguard Group, Inc.
6,339,022AU$86.8m23.5%no data
4.74%
Milford Asset Management, LTD
6,058,321AU$82.9m-7.68%1.19%
3.23%
Cameron Richard Pty Limited
4,123,084AU$56.4m0%no data
2.12%
Wilson Asset Management (International) Pty Ltd.
2,705,643AU$37.0m0%1.31%
2.06%
Stuart Andrew Pty. Ltd.
2,633,787AU$36.1m0%no data
1.95%
Norges Bank Investment Management
2,486,288AU$34.0m0%no data
1.89%
Trevor Scott
2,414,784AU$33.1m0%no data
1.76%
BlackRock, Inc.
2,246,840AU$30.8m1.17%no data
1.46%
Smithley Super Pty. Limited
1,870,000AU$25.6m0%no data
1.38%
Linwierik Super Pty. Limited
1,761,385AU$24.1m0%no data
0.69%
BetaShares Capital Limited
879,384AU$12.0m3.02%0.05%
0.59%
First Colby Co Pty Ltd
750,000AU$10.3m0%no data
0.59%
Mjhft Pty Ltd
750,000AU$10.3m0%no data
0.53%
Robin Congreve
671,637AU$9.2m0%no data
0.41%
State Street Global Advisors, Inc.
521,849AU$7.1m-0.38%no data
0.38%
Goldman Sachs Asset Management, L.P.
481,489AU$6.6m369%no data
0.37%
Emancipayte Pty ltd
470,756AU$6.4m0%no data
0.33%
Netwealth Investments Ltd.
421,309AU$5.8m0%0.04%
0.32%
He Zhao
405,000AU$5.5m0%no data
0.32%
Pfizer Inc.
404,072AU$5.5m0%no data
0.31%
Jonathan Pilcher
398,207AU$5.5m0%no data
0.31%
Jupiter Fund Management Plc
396,906AU$5.4m0%0.01%
0.21%
Patrick Donald Davies
264,634AU$3.6m0%no data
0.16%
Charles Schwab Investment Management, Inc.
201,087AU$2.8m0%no data
0.12%
Nordea Investment Management, AB
149,724AU$2.0m0.01%no data